Juha Rannikko

Medicine & Life Sciences

1. Age Groups 8%
2. Anti-Bacterial Agents 16%
3. Asymptomatic Infections 15%
4. Bacteremia 9%
5. beta-Lactams 14%
6. Candidemia 12%
7. Coinfection 12%
8. Contact Tracing 88%
9. Coronavirus 78%
10. Cough 11%
11. Databases 6%
12. Delivery of Health Care 6%
13. District Hospitals 73%
14. Dyspnea 55%
15. Epidemics 8%
16. Fever 9%
17. Finland 77%
18. Fungemia 89%
19. Guidelines 10%
20. Health 6%
21. Health Personnel 9%
22. History 6%
23. Hospital Emergency Service 8%
24. Hospitalization 46%
25. Immunocompromised Host 66%
26. Incidence 11%
27. Infections 9%
28. Medical Records 7%
29. Mycoplasma Pneumonia 17%
30. Mycoplasma pneumoniae 81%
31. Mycoses 63%
32. Odds Ratio 11%
33. Patient Admission 11%
34. Polymerase Chain Reaction 41%
35. Population 24%
36. Probiotics 66%
37. Public Health 7%
38. Quarantine 45%
39. Respiratory System 23%
40. Saccharomyces 61%
41. Saccharomyces boulardii 100%
42. SARS Virus 91%
43. Severe Acute Respiratory Syndrome 13%
44. Therapeutics 6%
45. University Hospitals 16%
46. Viruses 20%
47. Whole Genome Sequencing 18%
48. X-Rays 9%
49. Yeasts 7%
50. Young Adult 50%